Albemarle (ALB) EBT (2009 - 2026)

Albemarle (ALB) has reported EBT for 18 consecutive years, with $658.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 7443.6% year-over-year to $658.8 million; the trailing twelve-month figure through Jun 2026 stood at $207.2 million (up 118.34% YoY), and the FY2025 full-year result was -$552.1 million, up 68.7% from the prior year.
• EBT advanced to $658.8 million in Q2 2026 per ALB's latest filing, from $406.7 million in the prior quarter.
• Across five years, EBT topped out at $1.2 billion in Q1 2023 and bottomed at -$1.2 billion in Q3 2024.
• Historically, EBT has averaged $60.9 million across 5 years, with a median of $76.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: EBT jumped 10805.64% in 2022, then tumbled 1317.86% in 2025.
• Over 5 years, EBT stood at $863.1 million in 2022, then slumped by 206.7% to -$921.0 million in 2023, then jumped by 108.33% to $76.7 million in 2024, then sank by 1317.86% to -$934.4 million in 2025, then jumped by 170.5% to $658.8 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $658.8 million, $406.7 million, and -$934.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.